¹û¶³Ó°Ôº

XClose

Division of Infection and Immunity

Home
Menu

Portfolio of studies

Find details of studies being carried out by the ICRH.

Current studies

Study
BioAid 2019-2024Details
Human Immune Response Variant in Tuberculosis (HIRV TB)Details
Respiratory Virus Hospitalisation Study (Flu003 Plus)Details
Investigating patterns of influenza evolution in immunosuppressed patients (E3i)Details
Lateral flow assay (LFA) and reader for malaria detectionDetails
Feasibility of a serological assay for malaria eliminationDetails
Identification and validation of the determinants of variation in T cell immunity (TCV-BCG) tuningDetails
Tuning the immune response in tuberculosisDetails

Past studies

Study
Adjunctive Rifampicin to reduce early mortality from Staphylococcus aureus bacteremia (ARREST)Ìý
CoDifyÌý
ARISE Vitamin DÌý
ARISE LosmapimodÌý
Characterisation of Mucosally Transmitted HIV-1 Founder VirusesÌý
ENCEPH-UK cohort studiesÌý
Fever @ The Front Door pilot studyÌý
FLU-IVIG (intravenous immunoglobulin)Ìý
Gut Bacteria in Travellers (GUTBACK)Ìý
Are polymorphisms associated with HSV and VZV encephalitisÌý
Peripheral blood transcriptional profiling in HIVÌý
The pathogenesis and immune responses to Varicella Zoster Virus in Herpes Zoster studyÌý
Infectious diseases in Europe and Africa - IDEA studyÌý
Latent Tuberculosis: Evaluating the transcriptomic response to treatmentÌý
Accurate monitoring of Malarial DNA titres in patients post treatmentÌý
Defining protective immunity to human tuberculosisÌý
Reversing the effects of ageing in the cutaneous immune systemÌý
Leprosy studyÌý
HIV-1 viral reservoir following chemotherapyÌý
HIV-TST studyÌý
Comprehensive assessment of host and viral factors associated with HIV-1 elite controlÌý
Malaria DNA - Accurate monitoring of malarial DNA titres in patients post treatmentÌý
Protective immunity to tuberculosis extrapolated from challenge by TST (Protect TB)Ìý
Strong Treat 1 to 4Ìý
Multifunctional Integrated Microsystem for Rapid Point-of-Care TB Identification (TB MIMIC)Ìý